entity

ARK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ARK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

3Connections
30Hypotheses
2Analyses
2Outgoing
1Incoming
10Experiments
2Debates
AI portrait of ARK

AI-generated illustration · click image to enlarge

Regenerate portrait ↻

Wiki Pages (20)

Knowledge base pages for this entity

UCHL1 (PARK5) Pathway in Parkinson's Disease

mechanism · 3394 words

PARK7 — Parkinsonism Associated Deglycase (DJ-1)

gene · 3060 words

FBXO7 Protein (PARK15)

protein · 2779 words

ATP13A2 (PARK9) Pathway in Parkinson's Disease

mechanism · 2534 words

PARK2 - Parkin

gene · 2524 words

Outgoing (2)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:ARKdata_indataset_row0.00
DRONCactivatesprotein0.80

Incoming (1)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:ARKdata_indataset_row0.00

Targeting Hypotheses (30)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
Ketone Utilization Index as Metabolic Flexibility Biomarker 0.829 translational neuroscience Which metabolic biomarkers can distingui
CSF sTREM2 as Pharmacodynamic Biomarker for Therapeutic Wind 0.801 neuroimmunology TREM2 in Alzheimer's Disease: Mechanisms
NMN Supplementation Restores SIRT1/p66Shc/FOXO3 Epigenetic A 0.790 neurodegeneration epigenetic reprogramming aging neurons
Integrated Biomarker Panel for Therapeutic Window Identifica 0.784 neurodegeneration What are the precise temporal dynamics o
sTREM2 as Biomarker of Cystatin-C Therapeutic Efficacy 0.757 neurodegeneration View
p16^INK4a-CCF Axis as Senolytic Timing Biomarker 0.755 molecular biology What is the optimal therapeutic window t
SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK 0.738 Alzheimer's Disease Cell type vulnerability in Alzheimers Di
Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in 0.735 Alzheimer's disease TREM2 agonism vs antagonism in DAM micro
CSF YKL-40 as a Priming-Specific Chitinase Marker 0.714 biomarkers What biomarkers can reliably detect micr
Creatine Kinase System Capacity as Neural Energy Reserve Bio 0.707 translational neuroscience Which metabolic biomarkers can distingui
CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of A 0.705 - What blood-brain barrier permeability ch
Pericyte-targeted senolysis or senomorphic therapy will bene 0.700 neurodegeneration Does pericyte senescence drive BBB break
TDP-43 condensation thermodynamics as a therapeutic target a 0.699 neuroscience How can subcellular compartmentalization
mTORC1 Reactivation as Autophagy-Senescence Divergence Point 0.682 molecular biology What is the optimal therapeutic window t
Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification 0.677 translational neuroscience Which metabolic biomarkers can distingui
OPTN/TBK1 mutations create selective vulnerability by blocki 0.670 neurodegeneration What are the neuron-specific effects of
Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR- 0.662 - Blood-brain barrier permeability changes
TREM2-Driven Senescence Biomarker Index for Predicting Neuro 0.642 neurodegeneration Gene expression changes in aging mouse b
Circulating Endothelial Microvesicles Expressing Degraded Cl 0.640 - What blood-brain barrier permeability ch
Retromer-dependent retrograde endosomal signaling compartmen 0.620 neuroscience How can subcellular compartmentalization
CSF Biomarker-Guided ABCA7 Therapeutic Dosing 0.619 neurodegeneration Why does the V1613M variant reduce amylo
Dose-Response Framework: PINK1/Parkin Mitophagy as the Criti 0.614 neurodegeneration View
Age-Accelerated miR-155 Upregulation Primes Nigral Microglia 0.610 neuroinflammation How do regional, age, and sex-dependent
Neurovascular Permeability Score (NVPS): Composite Plasma + 0.600 - Blood-brain barrier permeability changes
CSF TREM2 Fragment Ratio Integrated with Neuroinflammatory C 0.000 biomarkers What biomarkers can reliably detect micr
TFEB Activation to Restore Lysosomal Function in Parkinson's 0.000 proteomics Quantitative proteomics of the aging syn
PINK1/PARK2 Mitophagy Enhancement for Microglial Polarizatio 0.000 Neuroinflammation Immune atlas neuroinflammation analysis
miR-33 Antisense-Enhanced APOE4 Lipidation as Senolytic Timi 0.000 molecular biology Is APOE4's reduced lipid binding pathoge
Plasma TREM2 Ectodomain Glycosylation Patterns as Microglial 0.000 biomarkers What biomarkers can reliably detect micr
TFEB Activation to Restore Lysosomal Biogenesis in Parkinson 0.000 proteomics Quantitative proteomics of the aging syn

Mentioning Analyses (2)

Scientific analyses that reference this entity

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or c

neurodegeneration | 2026-04-11 | 0 hypotheses

Do PINK1/PARKIN pathway enhancements rescue excitatory neuron vulnerability or e

neurodegeneration | 2026-04-11 | 0 hypotheses

Experiments (10)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
AECII-specific HMGCS2 overexpression in mouse pulmonary fibrosis validation idiopathic pulmonary fibrosis 0.950 0.00 C57BL/6 mice with AECII-specif proposed N/A
Ketogenic diet fat threshold analysis in wild-type mice validation metabolic disease 0.900 0.00 C57BL/6J wild-type mice proposed N/A
HMGCS2 gain-of-function in AECII lipid metabolism regulation exploratory idiopathic pulmonary fibrosis 0.900 0.00 human AECIIs proposed N/A
Ketogenic diet efficacy in diet-induced obese mice validation obesity, metabolic disease 0.900 0.00 C57BL/6J diet-induced obese mi proposed N/A
Autophagy receptor identification for stress granule elimination exploratory neurodegenerative diseases 0.900 0.00 cultured cells under arsenite proposed N/A
Epigenetic clocks association with brain aging patterns in older women exploratory cognitive impairment and demen 0.900 0.00 human patients proposed N/A
Chi3l1 deletion effects on baseline glial activation in mice validation baseline neuroinflammation 0.900 0.00 Chi3l1 knockout mice proposed N/A
iPSC-derived astrocyte-neuron co-culture mitochondrial transfer in PD exploratory Parkinson's disease 0.900 0.00 iPSC-derived dopaminergic neur proposed N/A
Microarray and single-cell RNA analysis of lipid metabolism genes exploratory idiopathic pulmonary fibrosis 0.850 0.00 human patients, mouse models proposed N/A
CHI3L1 variant association with AD progression in human patients exploratory Alzheimer's disease 0.850 0.00 human patients proposed N/A

Related Papers (20)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655] Jorstad NL, Close J, Johansen N, Yanny A Science 2023 186
TDP-43 Triggers Mitochondrial DNA Release via mPTP to Activate cGAS/STING in ALS [PMID:33031745] Yu CH, Davidson S, Harapas CR, Hilton JB Cell 2020 2
Targeted nanovesicular delivery of dexmedetomidine modulates microglial lysosoma [PMID:41778730] Zhang Y, Jiang H, Zhang F, Liao J Neural regeneration research 2026 0
Monocyte LOXHD1 and RHOB Expression Predictive of Progressive Systemic Sclerosis [PMID:40771159] Padilla CM, Lafyatis R, Gibson KF, Morse Arthritis Care Res (Hoboken) 2026 0
Obstructive sleep apnea, biomarker profiles, and clinical progression in Parkins [PMID:41499940] Zhu S, An D, Liu X Sleep Med 2026 0
The myocardial ischemic cascade network and multi-target synergistic interventio [PMID:41544859] Qi L, Yi J, Shen Y, Jiang H, Yao X et al Biochem Pharmacol 2026 0
SuPAR levels are increased in sera of euthymic patients with bipolar disorder an [PMID:41605346] Kök Kendirlioğlu B, Çörekli Kaymakçı E, J Affect Disord 2026 0
Chitinase-like Proteins YKL-40 and YKL-39 in Colorectal Cancer. [PMID:41677627] Ivanova T, Kazakova M, Dikov D, Dzhambov Cells 2026 0
Correction: CHI3L1: An Emerging Player in Neuroinflammation and Neurodegeneratio [PMID:41699333] Mushtaq Umar; Seh Bilal Ahmad; Khanday F Molecular Neurobiology 2026 0
UNC93B1 promotes pancreatic cancer progression through modulation of cGAS-STING [PMID:41716413] Yang H, Li Y, Su J, Zhang H, Zhu W et al Front Immunol 2026 0
Homoplantaginin ameliorates osteoarthritis by activating Sirt3/PINK1/Parkin sign [PMID:41720004] Zhang H, Xiao J, Yi Y, Chen B, Lv W et a Phytomedicine 2026 0
Kakkalide promotes spinal cord injury repair by regulating microglial M2 polariz [PMID:41720005] You T, Dai B, Ding X, He Z, Peng J et al Phytomedicine 2026 0
Association of Alzheimer's disease progression with YKL40 levels in peripheral b [PMID:41725729] Yang Q, Wang R, Pei J, Fu Q, Zhan Y et a Front Neurol 2026 0
Constitutive neuronal expression and disease-associated upregulation of chitinas [PMID:41762671] Gaur N, Angerer C, Gunes ZI, Ancau M, Wa Brain 2026 0
Interaction of mtROS-Immune-Inflammatory Vicious Cycle Activation in Sepsis-Indu [PMID:41905969] Wang Y, Yuan Q Clin Exp Pharmacol Physiol 2026 0
Plasma CHI3L1 as a marker of cognitive and structural brain changes in radiologi [PMID:41953284] Schneider R, Brand-Arzamendi K, Lim TR, BMJ Neurol Open 2026 0
Metformin attenuates HSV-1-induced neuropathic pain by restoring Sirt3-mediated [PMID:41896899] Yuanyuan Fang; Mengqiu Deng; Kesheng Hua Cell communication and signali 2026 0
Hydrogen-Enriched Hyaluronic Acid Dressing Ameliorates Diabetic Foot Ulcer via P [PMID:41906653] Xu Z, Cui X, Chu H, Wan H, Xie Y, Wang Y Journal of diabetes 2026 0
Inhibition of mitochondrial ROS turns LC3-associated phagocytosis to autophagy u [PMID:41896101] Cheng YL, Su MS, Liao CC, Chang TW, Hsie Journal of microbiology, immun 2026 0
Hyperoside stabilizes ACAT1 to promote fatty acid oxidation and attenuate kidney [PMID:41903436] Shan C, Szili-Torok T, Yue G, Zhang L, M Phytomedicine : international 2026 0

Debates (2)

Multi-agent debates referencing this entity

The debate revealed a critical gap: while PINK1/PARKIN deficiency correlates wit

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

The debate revealed a critical gap: while excitatory neurons show mitochondrial

closed · Rounds: 4 · Score: 0.50 · 2026-04-20

Related Research

Hypotheses and analyses mentioning ARK in their description or question text

p16^INK4a-CCF Axis as Senolytic Timing Biomarker

Score: 0.755 · molecular biology · 2026-04-21

**Molecular Mechanism and Rationale** The p16^INK4a-CCF axis represents a sophisticated temporal biomarker system that

SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy D

Score: 0.738 · Alzheimer's Disease · 2026-04-02

## Mechanistic Overview SIRT3-Mediated Mitochondrial Deacetylation Failure with PINK1/Parkin Mitophagy Dysfunction start

Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Anta

Score: 0.735 · Alzheimer's disease · 2026-04-04

## Mechanistic Overview Stage-Specific TREM2 Biomarker-Guided Switching — Agonist in Amyloid Phase, Antagonist in Tau Ph

CSF YKL-40 as a Priming-Specific Chitinase Marker

Score: 0.714 · biomarkers · 2026-04-22

## Mechanistic Overview CSF YKL-40 as a Priming-Specific Chitinase Marker starts from the claim that modulating CHI3L1/Y

Creatine Kinase System Capacity as Neural Energy Reserve Biomarker

Score: 0.707 · translational neuroscience · 2026-04-16

## Mechanistic Overview Creatine Kinase System Capacity as Neural Energy Reserve Biomarker starts from the claim that mo

CSF/Plasma AQP4 Polarization Index as a Novel Biomarker of Astrocyte Glymphatic

Score: 0.705 · unknown disease · 2026-04-26

Aquaporin-4 (AQP4) water channels are normally concentrated at astrocyte end-feet ensheathing cerebral microvessels. Ear

Pericyte-targeted senolysis or senomorphic therapy will benefit only an early bi

Score: 0.700 · neurodegeneration · 2026-04-25

Therapeutic benefit from pericyte-directed senescence interventions depends on stage. If BBB leak and dysfunction occur

TDP-43 condensation thermodynamics as a therapeutic target and biomarker for nuc

Score: 0.699 · neuroscience · 2026-04-26

FRAP-based measurement of TDP-43 liquid-liquid phase separation state provides a continuous biomarker of nuclear-cytopla

mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker

Score: 0.682 · molecular biology · 2026-04-21

## Mechanistic Overview mTORC1 Reactivation as Autophagy-Senescence Divergence Point Marker starts from the claim that m

Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker

Score: 0.677 · translational neuroscience · 2026-04-16

## Mechanistic Overview Dynamic Lactate-Pyruvate Ratio as Therapeutic Stratification Biomarker starts from the claim tha

OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-inde

Score: 0.670 · neurodegeneration · 2026-04-21

## Mechanistic Overview OPTN/TBK1 mutations create selective vulnerability by blocking PINK1-Parkin-independent mitophag

Pericyte-First Sequential Biomarker Cascade — Soluble PDGFR-β as Sentinel Event

Score: 0.662 · unknown disease · 2026-04-26

CSF soluble PDGFR-β shedding from pericytes as the earliest detectable molecular event in AD, preceding amyloid/tau path

TREM2-Driven Senescence Biomarker Index for Predicting Neurodegeneration Risk

Score: 0.642 · neurodegeneration · 2026-04-20

**Molecular Mechanism and Rationale** The TREM2 (Triggering Receptor Expressed on Myeloid cells 2) pathway represents a

Circulating Endothelial Microvesicles Expressing Degraded Claudin-5 as Specific

Score: 0.640 · unknown disease · 2026-04-26

Endothelial cells shed microvesicles (EMVs) during activation or injury. EMVs from degenerating brain endothelium carry

Retromer-dependent retrograde endosomal signaling compartmentalization as biomar

Score: 0.620 · neuroscience · 2026-04-26

VPS26/VPS29/VPS35 retromer complex maintains axonal endosomal signaling microdomains controlling TrkB/p75NTR trafficking